These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 21612985
1. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ. Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985 [Abstract] [Full Text] [Related]
2. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study. Comer GC, Smith MW, Hurwitz EL, Mitsunaga KA, Kessler R, Carragee EJ. Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617 [Abstract] [Full Text] [Related]
3. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2. Tepper G, Rabbani R, Yousefzadeh M, Prince D. Spine (Phila Pa 1976); 2013 May 01; 38(10):841-5. PubMed ID: 23403551 [Abstract] [Full Text] [Related]
4. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications. Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH. J Neurosurg Spine; 2014 Dec 01; 21(6):851-60. PubMed ID: 25279655 [Abstract] [Full Text] [Related]
5. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article. Burkus JK, Dryer RF, Peloza JH. J Neurosurg Spine; 2013 Feb 01; 18(2):112-21. PubMed ID: 23199378 [Abstract] [Full Text] [Related]
6. Retrograde ejaculation after anterior lumbar spine surgery. Lindley EM, McBeth ZL, Henry SE, Cooley R, Burger EL, Cain CM, Patel VV. Spine (Phila Pa 1976); 2012 Sep 15; 37(20):1785-9. PubMed ID: 22472808 [Abstract] [Full Text] [Related]
7. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear. Glassman SD, Gum JL, Crawford CH, Shields CB, Carreon LY. Spine J; 2011 Jun 15; 11(6):522-6. PubMed ID: 20598649 [Abstract] [Full Text] [Related]
8. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study. Lykissas MG, Aichmair A, Sama AA, Hughes AP, Lebl DR, Cammisa FP, Girardi FP. Spine J; 2014 Feb 01; 14(2):217-24. PubMed ID: 24269858 [Abstract] [Full Text] [Related]
9. Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Sasso RC, Kenneth Burkus J, LeHuec JC. Spine (Phila Pa 1976); 2003 May 15; 28(10):1023-6. PubMed ID: 12768143 [Abstract] [Full Text] [Related]
10. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost? Mannion RJ, Nowitzke AM, Wood MJ. Spine J; 2011 Jun 15; 11(6):527-33. PubMed ID: 20739225 [Abstract] [Full Text] [Related]
11. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion. Singh K, Nandyala SV, Marquez-Lara A, Cha TD, Khan SN, Fineberg SJ, Pelton MA. Spine J; 2013 Sep 15; 13(9):1118-25. PubMed ID: 24029138 [Abstract] [Full Text] [Related]
12. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Crawford CH, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD. Spine (Phila Pa 1976); 2009 Jun 01; 34(13):1390-4. PubMed ID: 19440166 [Abstract] [Full Text] [Related]
13. Retrospective analysis of L5-S1 axial lumbar interbody fusion (AxiaLIF): a comparison with and without the use of recombinant human bone morphogenetic protein-2. Gerszten PC, Tobler WD, Nasca RJ. Spine J; 2011 Nov 01; 11(11):1027-32. PubMed ID: 22122835 [Abstract] [Full Text] [Related]
14. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article. Lubelski D, Abdullah KG, Nowacki AS, Alvin MD, Steinmetz MP, Chakka S, Li Y, Gajewski N, Benzel EC, Mroz TE. J Neurosurg Spine; 2013 Feb 01; 18(2):126-31. PubMed ID: 23231356 [Abstract] [Full Text] [Related]
15. Complications associated with single-level transforaminal lumbar interbody fusion. Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, Hilibrand AS, Albert TJ. Spine J; 2009 Aug 01; 9(8):623-9. PubMed ID: 19482519 [Abstract] [Full Text] [Related]
16. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Slosar PJ, Josey R, Reynolds J. Spine J; 2007 Aug 01; 7(3):301-7. PubMed ID: 17482113 [Abstract] [Full Text] [Related]
17. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions. Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D. Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173 [Abstract] [Full Text] [Related]
18. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients. Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R. Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1137-45. PubMed ID: 23354111 [Abstract] [Full Text] [Related]
19. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2. Lee DD, Kim JY. J Orthop Surg Res; 2017 Aug 25; 12(1):126. PubMed ID: 28841904 [Abstract] [Full Text] [Related]